{
    "2019-02-26": [
        [
            {
                "time": "",
                "original_text": "股获券商买入评级 恒华科技目标涨幅达55.84%",
                "features": {
                    "keywords": [
                        "恒华科技",
                        "券商",
                        "买入评级",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报:科创板加快,创新药产业链标的估值有望重构",
                "features": {
                    "keywords": [
                        "医药生物",
                        "科创板",
                        "创新药",
                        "估值重构"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}